Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
批准号:
8939810
负责人:
GRIFFIN RODGERS
金额:
$32.92万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
13q12-1313q1413q14.314qAmericanBRCA2 geneBiologicalBiological ProcessCXCL12 geneCadherinsCancer Cell GrowthCancer EtiologyCathepsinsCell AdhesionCell ProliferationCell surfaceCellsCessation of lifeChromosomesColon CarcinomaColonic NeoplasmsDiagnosisDiagnosticEctopic ExpressionEvaluationExonsFamilyFamily memberGene ExpressionGene Expression ProfileGene ProteinsGene TargetingGenesGeneticGlycoproteinsGoalsHumanHuman GenomeIn VitroInflammationKnockout MiceLectinLoss of HeterozygosityMalignant neoplasm of prostateMessenger RNAMetastatic Neoplasm to the BoneMolecularMusNatural ImmunityNeoplasm MetastasisPlayProstateProstate AdenocarcinomaProstatic Intraepithelial NeoplasiasProstatic NeoplasmsRB1 geneReportingRetinoblastomaRoleSamplingSeminal fluidSerumSignaling Pathway GeneSolid NeoplasmSonic hedgehog proteinStem cellsStomach NeoplasmsSusceptibility GeneTissuesTumor Suppressor GenesTumor Suppressor Proteinsage relatedcancer typecell growthepithelial to mesenchymal transitionforkhead proteingene functionhuman GW112 proteinimprovedin vivomalignant breast neoplasmmalignant stomach neoplasmmenmouse modelnovel markerolfactomedinoutcome forecastprognosticprostate cancer cellsmoothened signaling pathwaystemtherapeutic targettumor progression
中文摘要
人类嗅消素4基因(OLFM4)编码一种与嗅消素相关的糖蛋白。OLFM4通常在包括前列腺在内的有限组织中表达,但其在前列腺中的生物学功能在很大程度上是未知的。olfactomedin 4 (OLFM4)基因表达缺失与人类高级别前列腺癌相关。遗传学研究发现,大约25%的人类前列腺癌样本中存在嗅去蛋白4 (OLFM4)基因缺失。为了探索OLFM4功能的细胞和分子机制,我们研究了OLFM4敲除小鼠模型和缺乏OLFM4表达的人前列腺癌细胞。对olfm4基因敲除小鼠进行的前列腺表型研究发现,偶尔发生的前列腺上皮内瘤变和前列腺腺癌以年龄依赖的方式发生。olfm4基因敲除小鼠在3月龄和15月龄时前列腺组织的基因表达特征显示,与前列腺肿瘤进展相关的基因发生了显著变化。olfm4敲除小鼠前列腺中Sonic刺猬信号通路和靶基因显著上调。重要的是,我们发现Olfactomedin 4通过下调刺猬信号通路基因和靶基因活性抑制前列腺干细胞/祖细胞生长和上皮-间质转化(EMT)。此外,我们证明OLFM4通过与sonic hedgehog蛋白的直接相互作用抑制hedgehog信号通路。这些发现表明OLFM4在前列腺肿瘤进展中起着关键作用,OLFM4蛋白有潜力作为提高前列腺癌诊断/预后准确性的新标记物和治疗方法的可能靶点。
英文摘要
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein. OLFM4 is normally expressed in a limited number of tissues, including the prostate, but its biological functions in prostate are largely unknown. Loss of olfactomedin 4 (OLFM4) gene expression is associated with high grade of human prostate cancer. Genetics studies have found that deletions within the olfactomedin 4 (OLFM4) gene occur in approximately 25% of human prostate-cancer samples. To explore cellular and molecular mechanisms underlying OLFM4 functions, we investigated Olfm4-knockout mouse model and human prostate cancer cells that lack OLFM4 expression. Phenotypically studies of prostate from Olfm4-knockout mice found that sporadically developed prostatic intraepithelial neoplasia and prostatic adenocarcinoma in an age-dependent manner. The gene-expression signature of prostate tissues from Olfm4-knockout mice at 3 month-old and 15 month-old revealed significant changes for genes associated with prostate neoplastic progression. Sonic hedgehog-signaling pathway and target genes were significantly up-regulated in prostate from Olfm4-knockout mice. Importantly, we found Olfactomedin 4 inhibits prostate stem/progenitor cell growth and epithelial-to-mesenchymal transition (EMT) through down-regulated the hedgehog-signaling pathway genes and target genes activities. Moreover, we demonstrated that OLFM4 inhibited the hedgehog-signaling pathway via direct interaction with sonic hedgehog protein. These findings suggest that OLFM4 plays a critical role in prostate neoplastic progression and that OLFM4 protein has potential as a new marker for improving diagnostic/prognostic accuracy and likely targets for therapeutic approaches to prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:8939812
-
项目类别:
-
资助金额:$32.92万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
-
批准号:8557968
-
项目类别:
-
资助金额:$70.74万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
-
批准号:8557970
-
项目类别:
-
资助金额:$70.74万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma negatively modulates TLR4 signaling in macrophages
-
批准号:8149534
-
项目类别:
-
资助金额:$69.25万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
-
批准号:8149535
-
项目类别:
-
资助金额:$69.25万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:9157363
-
项目类别:
-
资助金额:$56.41万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
-
批准号:8344821
-
项目类别:
-
资助金额:$83.2万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:8557967
-
项目类别:
-
资助金额:$70.74万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:9357228
-
项目类别:
-
资助金额:$58.81万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 is a key regulator of human neutrophil function
-
批准号:10012677
-
项目类别:
-
资助金额:$52.01万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:10253822
-
项目类别:
-
资助金额:$40.45万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 is a key regulator of colon cancer progression
-
批准号:8939811
-
项目类别:
-
资助金额:$32.92万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:8344822
-
项目类别:
-
资助金额:$83.2万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:8344820
-
项目类别:
-
资助金额:$83.2万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Effects Of Thalidomide and Stem Cell Factor On Fetal Hemoglobin Synthesis
-
批准号:7969153
-
项目类别:
-
资助金额:$34.29万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
-
批准号:8746604
-
项目类别:
-
资助金额:$38.54万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:8746605
-
项目类别:
-
资助金额:$38.54万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:10706165
-
项目类别:
-
资助金额:$59.52万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4- a key regulator of human neutrophil function, role in small intestinal adenocarcinoma.
-
批准号:10253823
-
项目类别:
-
资助金额:$40.45万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:10929107
-
项目类别:
-
资助金额:$64.05万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
国内基金
海外基金
CTCF通过介导染色体13q14 基因组区异常构象促进视网膜母细胞瘤发生的机制研究
-
批准号:81802739
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:文旭洋
-
依托单位:
13q14染色体缺失通过下调miRNA表达参与多发性骨髓瘤血管新生
-
批准号:30700331
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2007
-
负责人:孙春艳
-
依托单位: